Limits...
Prostatic urethral lift: A minimally invasive treatment for benign prostatic hyperplasia.

Garcia C, Chin P, Rashid P, Woo HH - Prostate Int (2015)

Bottom Line: Furthermore, improvement in LUTS may be attained while preserving erectile and ejaculatory function.Adverse effects associated with the PUL procedure are mild to moderate, and are transient in nature.The PUL procedure provides an alternative for men seeking treatment for bothersome LUTS, with fewer side-effects.

View Article: PubMed Central - PubMed

Affiliation: Sydney Adventist Hospital Clinical School, University of Sydney, NSW, Australia.

ABSTRACT
Prostatic urethral lift (PUL) is a minimally invasive procedure for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia. The procedure may be performed under local, spinal, or general anesthesia. The PUL procedure involves the delivery of implants that retract obstructing prostate lobes. Unlike other benign prostatic hyperplasia treatment options including pharmacological therapy, and the current invasive gold-standard transurethral resection of the prostate, the PUL procedure achieves quantifiable improvements in functional outcomes and quality of life, in the absence of major adverse events. Furthermore, improvement in LUTS may be attained while preserving erectile and ejaculatory function. Adverse effects associated with the PUL procedure are mild to moderate, and are transient in nature. The PUL procedure provides an alternative for men seeking treatment for bothersome LUTS, with fewer side-effects.

No MeSH data available.


Related in: MedlinePlus

The delivery sequence of the Urolift device. (A) The device in introduced under cystosopic guidance; (B) the lateral lobes of the prostate are compressed by the device and the needle is deployed; and (C) additional sutures are delivered if needed to maintain (D) a patent urethral lumen.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4494639&req=5

fig2: The delivery sequence of the Urolift device. (A) The device in introduced under cystosopic guidance; (B) the lateral lobes of the prostate are compressed by the device and the needle is deployed; and (C) additional sutures are delivered if needed to maintain (D) a patent urethral lumen.

Mentions: Once the tip of the device is in the desired position it is deployed using the following sequence (Fig. 2):(1)


Prostatic urethral lift: A minimally invasive treatment for benign prostatic hyperplasia.

Garcia C, Chin P, Rashid P, Woo HH - Prostate Int (2015)

The delivery sequence of the Urolift device. (A) The device in introduced under cystosopic guidance; (B) the lateral lobes of the prostate are compressed by the device and the needle is deployed; and (C) additional sutures are delivered if needed to maintain (D) a patent urethral lumen.
© Copyright Policy - CC BY-NC-ND
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4494639&req=5

fig2: The delivery sequence of the Urolift device. (A) The device in introduced under cystosopic guidance; (B) the lateral lobes of the prostate are compressed by the device and the needle is deployed; and (C) additional sutures are delivered if needed to maintain (D) a patent urethral lumen.
Mentions: Once the tip of the device is in the desired position it is deployed using the following sequence (Fig. 2):(1)

Bottom Line: Furthermore, improvement in LUTS may be attained while preserving erectile and ejaculatory function.Adverse effects associated with the PUL procedure are mild to moderate, and are transient in nature.The PUL procedure provides an alternative for men seeking treatment for bothersome LUTS, with fewer side-effects.

View Article: PubMed Central - PubMed

Affiliation: Sydney Adventist Hospital Clinical School, University of Sydney, NSW, Australia.

ABSTRACT
Prostatic urethral lift (PUL) is a minimally invasive procedure for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia. The procedure may be performed under local, spinal, or general anesthesia. The PUL procedure involves the delivery of implants that retract obstructing prostate lobes. Unlike other benign prostatic hyperplasia treatment options including pharmacological therapy, and the current invasive gold-standard transurethral resection of the prostate, the PUL procedure achieves quantifiable improvements in functional outcomes and quality of life, in the absence of major adverse events. Furthermore, improvement in LUTS may be attained while preserving erectile and ejaculatory function. Adverse effects associated with the PUL procedure are mild to moderate, and are transient in nature. The PUL procedure provides an alternative for men seeking treatment for bothersome LUTS, with fewer side-effects.

No MeSH data available.


Related in: MedlinePlus